ClinicalTrialsFinder

Head and Neck Squamous Cell Carcinoma (HNSCC) Clinical Trials in Philadelphia, Pennsylvania

1 recruitingPhiladelphia, Pennsylvania

Showing 1–1 of 1 trials

Recruiting
Phase 1

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Solid Tumor+7 more
Exelixis1,314 enrolled122 locationsNCT05176483